Search Results Search Sort by RelevanceMost Recent In the Literature Jun 2019 Disentangling Evidence and Preference in Patient-Clinician Concordance Discussions Leah Z. G. Rand, DPhil and Zackary Berger, MD, PhD How should evidence be used to interpret and inform whether to accommodate patients’ requests for clinicians with specific traits? AMA J Ethics. 2019;21(6):E505-512. doi: 10.1001/amajethics.2019.505. Medicine and Society Aug 2019 Does Incorporating Cost-Effectiveness Analysis Into Prescribing Decisions Promote Drug Access Equity? Michael J. DiStefano, MBE and Jonathan S. Levin, MPH Advances in CEA methodology might integrate equity at the cost of transparency. AMA J Ethics. 2019;21(8):E679-685. doi: 10.1001/amajethics.2019.679. Case and Commentary Aug 2019 How Should Physicians Steward Limited Resources While Ensuring That Patients Can Access Needed Medicines? Pete Croughan and Rebekah E. Gee, MD, MPH Louisiana has a subscription model for hepatitis C treatment, but costly medications challenge states’ capacities to cover patients. AMA J Ethics. 2019;21(8):E630-635. doi: 10.1001/amajethics.2019.630. Policy Forum Aug 2019 Why Are Biosimilars Not Living up to Their Promise in the US? Mike Z. Zhai, Ameet Sarpatwari, JD, PhD, and Aaron S. Kesselheim, MD, JD, MPH Overall utilization of the few biosimilars currently available to patients has been limited. AMA J Ethics. 2019;21(8):E668-678. doi: 10.1001/amajethics.2019.668. Original Research Feb 2019 Can AI Help Reduce Disparities in General Medical and Mental Health Care? Irene Y. Chen, Peter Szolovits, PhD, and Marzyeh Ghassemi, PhD As machine learning becomes increasingly common in health care, these systems’ data, algorithms, and recommendations raise critical justice questions. AMA J Ethics. 2019;21(2):E167-179. doi: 10.1001/amajethics.2019.167. Case and Commentary Mar 2020 How Should Organizations Respond to Repeated Noncompliance by Prominent Researchers? Min-Fu Tsan, MD, PhD and Grace L. Tsan, OD IRBs must report human subject research protocol deviations and university leadership might also need to motivate compliance with federal regulations. AMA J Ethics. 2020;22(3):E201-208. doi: 10.1001/amajethics.2020.201. Health Law Mar 2020 Which Legal Approaches Help Limit Harms to Patients From Clinicians’ Conscience-Based Refusals? Rachel Kogan, JD, Katherine L. Kraschel, JD, and Claudia E. Haupt, PhD, JSD When a clinician refuses to do a procedure consistent with standard of care for a patient, legal resources can be helpful. AMA J Ethics. 2020;22(3):E209-216. doi: 10.1001/amajethics.2020.209. Medicine and Society Mar 2020 How Should We Judge Whether and When Mission Statements Are Ethically Deployed? Kellie E. Schueler and Debra B. Stulberg, MD Mission statements offer limited benefit when patients do not have meaningful choices about where to seek care and can be misused. AMA J Ethics. 2020;22(3):E239-247. doi: 10.1001/amajethics.2020.239. Policy Forum Aug 2020 Revisiting the WHO Analgesic Ladder for Surgical Management of Pain Laura Stone McGuire, MD and Konstantin Slavin, MD A 3-step analgesic ladder was introduced in 1986 and needs change. Surgical interventions could reduce opioid use and motivate expansion of current pain management approaches. AMA J Ethics. 2020;22(8):E695-701. doi: 10.1001/amajethics.2020.695. Medical Education Nov 2002 Cost-Effective Prescribing Susanna Smith Virtual Mentor. 2002;4(11):338-340. doi: 10.1001/virtualmentor.2002.4.11.puhl1-0211. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
In the Literature Jun 2019 Disentangling Evidence and Preference in Patient-Clinician Concordance Discussions Leah Z. G. Rand, DPhil and Zackary Berger, MD, PhD How should evidence be used to interpret and inform whether to accommodate patients’ requests for clinicians with specific traits? AMA J Ethics. 2019;21(6):E505-512. doi: 10.1001/amajethics.2019.505.
Medicine and Society Aug 2019 Does Incorporating Cost-Effectiveness Analysis Into Prescribing Decisions Promote Drug Access Equity? Michael J. DiStefano, MBE and Jonathan S. Levin, MPH Advances in CEA methodology might integrate equity at the cost of transparency. AMA J Ethics. 2019;21(8):E679-685. doi: 10.1001/amajethics.2019.679.
Case and Commentary Aug 2019 How Should Physicians Steward Limited Resources While Ensuring That Patients Can Access Needed Medicines? Pete Croughan and Rebekah E. Gee, MD, MPH Louisiana has a subscription model for hepatitis C treatment, but costly medications challenge states’ capacities to cover patients. AMA J Ethics. 2019;21(8):E630-635. doi: 10.1001/amajethics.2019.630.
Policy Forum Aug 2019 Why Are Biosimilars Not Living up to Their Promise in the US? Mike Z. Zhai, Ameet Sarpatwari, JD, PhD, and Aaron S. Kesselheim, MD, JD, MPH Overall utilization of the few biosimilars currently available to patients has been limited. AMA J Ethics. 2019;21(8):E668-678. doi: 10.1001/amajethics.2019.668.
Original Research Feb 2019 Can AI Help Reduce Disparities in General Medical and Mental Health Care? Irene Y. Chen, Peter Szolovits, PhD, and Marzyeh Ghassemi, PhD As machine learning becomes increasingly common in health care, these systems’ data, algorithms, and recommendations raise critical justice questions. AMA J Ethics. 2019;21(2):E167-179. doi: 10.1001/amajethics.2019.167.
Case and Commentary Mar 2020 How Should Organizations Respond to Repeated Noncompliance by Prominent Researchers? Min-Fu Tsan, MD, PhD and Grace L. Tsan, OD IRBs must report human subject research protocol deviations and university leadership might also need to motivate compliance with federal regulations. AMA J Ethics. 2020;22(3):E201-208. doi: 10.1001/amajethics.2020.201.
Health Law Mar 2020 Which Legal Approaches Help Limit Harms to Patients From Clinicians’ Conscience-Based Refusals? Rachel Kogan, JD, Katherine L. Kraschel, JD, and Claudia E. Haupt, PhD, JSD When a clinician refuses to do a procedure consistent with standard of care for a patient, legal resources can be helpful. AMA J Ethics. 2020;22(3):E209-216. doi: 10.1001/amajethics.2020.209.
Medicine and Society Mar 2020 How Should We Judge Whether and When Mission Statements Are Ethically Deployed? Kellie E. Schueler and Debra B. Stulberg, MD Mission statements offer limited benefit when patients do not have meaningful choices about where to seek care and can be misused. AMA J Ethics. 2020;22(3):E239-247. doi: 10.1001/amajethics.2020.239.
Policy Forum Aug 2020 Revisiting the WHO Analgesic Ladder for Surgical Management of Pain Laura Stone McGuire, MD and Konstantin Slavin, MD A 3-step analgesic ladder was introduced in 1986 and needs change. Surgical interventions could reduce opioid use and motivate expansion of current pain management approaches. AMA J Ethics. 2020;22(8):E695-701. doi: 10.1001/amajethics.2020.695.
Medical Education Nov 2002 Cost-Effective Prescribing Susanna Smith Virtual Mentor. 2002;4(11):338-340. doi: 10.1001/virtualmentor.2002.4.11.puhl1-0211.